GlaxoSmithKline, Theravance lung drug works in asthma study
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline’s inhaled lung drug worked in a study of adult asthma patients, setting the stage for a potential US filing to expand use of the therapy.